Veterinary CRO Market to Surpass US$ 1.6 Billion by 2035, Driven by Rising Pet Ownership and Advancements in Animal Health Research | Latest Report TMR

The global veterinary Contract Research Organization (CRO) market was valued at US$ 770.8 Mn in 2024 and is projected to surpass US$ 1.6 Bn by 2035, expanding at a CAGR of 7.1% from 2025 to 2035. Market growth is primarily driven by increasing pet ownership, rising awareness of animal health and wellness, technological advancements in veterinary medicine, and growing investments in research and development for animal health products.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86567

Market Overview
Veterinary Contract Research Organizations (CROs) play a vital role in the development, testing, and regulatory approval of veterinary pharmaceuticals, vaccines, and medical devices. These organizations provide a wide range of services, including preclinical research, clinical trial management, regulatory support, data analysis, and post-market surveillance.

Preclinical studies conducted by veterinary CROs involve laboratory testing and toxicology assessments to evaluate product safety and biological interactions. Following this, CROs manage clinical trials across multiple phases to assess product efficacy in target animal populations while ensuring compliance with regulatory standards set by authorities such as the FDA and EMA.

Beyond research and trials, veterinary CROs also offer specialized consultancy services, helping pharmaceutical and biotechnology companies navigate complex regulatory landscapes and optimize product development strategies. As the veterinary healthcare sector evolves, CROs are becoming strategic partners in delivering innovative and compliant animal health solutions.

Key Market Growth Drivers

Growing Awareness about Animal Health and Wellness
Increasing awareness regarding animal welfare is a major factor driving the veterinary CRO market. The rising trend of pet ownership globally has led to greater attention toward preventive healthcare, routine veterinary check-ups, and advanced medical treatments.

Pet owners are becoming more informed about animal health through digital platforms, social media, and online communities, encouraging proactive healthcare management. This heightened awareness has significantly increased the demand for veterinary services and research into innovative treatments.

Technological Advancements in Veterinary Medicine and Diagnostics
Technological innovation is transforming veterinary medicine and significantly contributing to market growth. Advanced diagnostic tools such as ultrasound, MRI, and CT scans enable early and accurate disease detection.

Molecular diagnostics, including PCR-based technologies and next-generation sequencing, are enhancing the ability to detect pathogens and genetic disorders. These advancements are particularly important in managing zoonotic diseases and preventing potential public health risks.

Analysis of Key Players

The veterinary CRO market is highly competitive, with key players focusing on strategic collaborations, innovation, and service expansion. Leading companies include Charles River Laboratories, IDEXX Laboratories, Inc., BioAgile Therapeutics Private Limited, Royal GD, KLIFOVET GmbH, Argenta Holdco Limited, Cebiphar, Clinvet, STATKING Clinical Services, OCRvet, LÖHLEIN & WOLF VET RESEARCH, VETSPIN SRL, Inotiv, Knoell, and Cloudbyz.

These players are strengthening their market position by offering comprehensive end-to-end CRO services, from preclinical studies to regulatory approvals. Strategic partnerships and acquisitions are enabling companies to expand their geographic footprint and enhance research capabilities.

Market Challenges & Opportunities

The veterinary CRO market faces challenges such as stringent regulatory requirements, high costs associated with clinical trials, and the need for specialized expertise in veterinary research. Compliance with evolving regulatory standards can increase operational complexity and time-to-market for new products.

However, these challenges also present opportunities for growth. The increasing focus on zoonotic diseases and their impact on public health is driving demand for veterinary research. Moreover, the globalization of the veterinary industry is opening new opportunities in emerging markets, where CROs can expand their presence through partnerships and collaborations.

Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/veterinary-cro-market.html

Recent Developments

• In January 2025, Argenta announced strategic realignment of its CRO platform. Argenta's CRO platform offers a comprehensive set of capabilities inclusive of regulatory, pre-clinical, and clinical CRO services. The realignment of the CRO business is poised to strengthen the company's customer value proposition by improving their capabilities to provide end-to-end R&D and product development journey within the animal health industry.

• In October 2024, Clinglobal announced that it had completed the acquisition of OCRvet, a European CRO specializing in translational and animal health field trials. The acquisition has strengthened the company's presence across Europe, with teams in France, Italy, and Poland.

Market Segmentation

By Service Type
• Clinical Trial Services (Leading segment)
• Preclinical Services
• Regulatory Affairs
• Post-Market Surveillance

Clinical trial services dominate the market due to strict regulatory requirements for safety and efficacy testing of veterinary products.

By Animal Type
• Companion Animals (Largest segment)
• Livestock Animals

The companion animals segment leads the market, driven by increasing pet ownership and rising expenditure on pet healthcare. The growing prevalence of chronic diseases in pets further fuels demand for advanced treatments and clinical research.

Regional Outlook
North America (Leading Region)

North America dominated the veterinary CRO market in 2024, supported by advanced healthcare infrastructure and strong research and development capabilities. The presence of leading pharmaceutical and biotechnology companies in the United States and Canada drives demand for CRO services.

The region also benefits from a well-established pet ownership culture, with increasing spending on preventive care and advanced treatments. Technological advancements, including telemedicine and wearable health devices, are further enhancing veterinary research and clinical trial capabilities.

Other Regions
• Europe: Strong presence of CROs and increasing research collaborations
• Asia Pacific: Rapid growth due to expanding veterinary healthcare sector
• Latin America & Middle East & Africa: Emerging markets with increasing awareness and investment in animal health

Why Buy This Report?

• Comprehensive analysis of market size and growth forecasts through 2035
• Detailed insights into key drivers, challenges, and opportunities
• In-depth profiling of major market players and competitive landscape
• Region-wise and segment-wise market intelligence
• Strategic insights for stakeholders, investors, and industry participants

Buy this Premium Research Report for exclusive, in-depth insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=86567<ype=S

FAQs

1. What is the current size of the veterinary CRO market?
The market was valued at US$ 770.8 Mn in 2024.

2. What is the expected growth rate of the market?
The market is projected to grow at a CAGR of 7.1% from 2025 to 2035.

3. Which region dominates the veterinary CRO market?
North America is the leading region in the global market.

4. Which segment leads the market?
Clinical trial services and companion animals segments hold the largest shares.

5. What are the key growth drivers of the market?
Key drivers include rising pet ownership, increasing awareness of animal health, technological advancements, and growing R&D investments.

More Trending Reports by Transparency Market Research -

Regenerative Medicine Market: https://www.transparencymarketresearch.com/regenerative-medicines-market.html

Healthcare Biometrics Market: https://www.transparencymarketresearch.com/healthcare-biometrics-market.html

Multiplexed Diagnostics Market: https://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html

Red Biotechnology Market: https://www.transparencymarketresearch.com/red-biotechnology-market.html

Intrathecal Pumps Market: https://www.transparencymarketresearch.com/intrathecal-pumps-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com

This release was published on openPR.